NASDAQ: NRC - National Research Corporation

Yield per half year: -12.81%
Sector: Healthcare

Share chart National Research Corporation


About

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

More details
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Main settings

Выручка 0.1197
EBITDA 0.0417
Число акций ао 0.02505 млрд
P/E 35.58
P/S 8.93
P/BV 56.03
EV/EBITDA 25.42
Цена ао 41.32
ISIN US6373722023
Сайт https://www.nrchealth.com
Change price per day: -3.22% (40.72)
Change price per week: -5.04% (41.5)
Change price per month: -4.3% (41.18)
Change price per 3 month: -13.76% (45.7)
Change price per half year: -12.81% (45.2)
Change price per year: +5.57% (37.33)
Change price per year to date: -7.14% (42.44)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 8.93 1
P/BV 56.03 1
P/E 35.58 6
EV/EBITDA 25.42 6
Total:

Efficiency

Title Value Grade
ROA, % 22.08 7
ROE, % 40.41 10
Total:

Dividends

Title Value Grade
Div yield, % 1.1378 2
DSI 0.79 8
Total:

Debt

Title Value Grade
Debt/EBITDA 0.4277 10
Total:

Growth impulse

Title Value Grade
Profit growth, % 9.57 2
Share price growth, % 0 0
Dividend growth, % 39.29 8
Total:

Dividends

Dividends, % Dividends Result of period Buy before Register closing date Payment before
0.29% 0.12 III кв. 2023 26.12.2023 28.12.2023 12.01.2024

Main owners

Institutions Volume Share, %
Kayne Anderson Rudnick Investment Management LLC 3194629 13
Blackrock Inc. 1015583 4.13
Vanguard Group Inc 980693 3.99
Morgan Stanley 940538 3.83
Conestoga Capital Advisors, LLC 780806 3.18
Dimensional Fund Advisors LP 636402 2.59
QV Investors Inc. 395102 1.61
Renaissance Technologies, LLC 367384 1.49
Geode Capital Management, LLC 338078 1.38
State Street Corporation 327633 1.33

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Michael D. Hays Founder, CEO, President & Director 131.65k 1955 (69 years)
Mr. Kevin R. Karas CPA Senior VP of Finance, CFO, Treasurer & Secretary 292.81k 1958 (66 years)
Ms. Jona S. Raasch Chief Operating Officer 308.01k 1959 (65 years)
Ms. Helen L. Hrdy Chief Growth Officer 291.31k 1965 (59 years)
Mr. Jon Boumstein Chief Delivery Officer N/A
Dr. Gregory Makoul M.S., Ph.D. Chief Transformation Officer N/A
Linda Stacy Vice President of Finance N/A
Megan Charko Senior Manager of Content Marketing N/A

About company

Address: United States, Lincoln. NE, 1245 Q Street - open in Google maps, open in Yandex maps
Website: https://www.nrchealth.com
Phone: +tel:4024752525